Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| NCI-2021-09908 | Other Identifier | NCI-CTRP Clinical Trials Registry |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To understand more about the opinions of patients and health providers on the use of telemedicine in radiation oncology.
Primary Objective:
To characterize patient and provider satisfaction with telemedicine in RO
Secondary Objective:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Telemedicine Visits | Participants are asked to fill out a survey about their experience. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Survey Administration | Behavioral | Patients and providers complete survey over 10 minutes about their perspectives on the use of telemedicine |
|
| Measure | Description | Time Frame |
|---|---|---|
| Patient satisfaction survey with telemedicine in radiation oncology (RO) | Sensitivity analyses will be performed with those rating 9 or higher or less than 9, and for those who "agree" or "strongly agree" with whether they are satisfied with telemedicine compared to those who give other answers. | through study completion and average of one year. |
| Provider satisfaction survey with telemedicine in radiation oncology (RO) | Sensitivity analyses will be performed with those rating 9 or higher or less than 9, and for those who "agree" or "strongly agree" with whether they are satisfied with telemedicine compared to those who give other answers. | through study completion and average of one year. |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
• Protected populations such as adults unable to consent, pregnant women, prisoners, and individuals who are not yet adults will be excluded
Not provided
Not provided
Not provided
MD Anderson Cancer Center
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Chenyang Wang, MD | M.D. Anderson Cancer Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States |
Not provided
| Label | URL |
|---|---|
| MD Anderson Cancer Center | View source |
Not provided
Not provided
| ID | Term |
|---|---|
| D019337 | Hematologic Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D006402 | Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided